Breaking News Instant updates and real-time market news.

MMSI

Merit Medical

$23.90

0.3 (1.27%)

09:28
10/19/16
10/19
09:28
10/19/16
09:28

Merit Medical completes enrollment in EVOLVE study

Merit Medical Systems announced that it has completed enrollment in its EVOLVE study. The study is investigating whether the unique valve in the EndoMAXX EVT stent can facilitate swallowing by treating the esophageal stricture while also limiting reflux.

  • 26

    Oct

  • 17

    Nov

  • 29

    Nov

MMSI Merit Medical
$23.90

0.3 (1.27%)

10/26/15
10/26/15
UPGRADE

On The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: AMC Networks (AMCX) upgraded to Buy from Outperform at CLSA... AMRI (AMRI) upgraded to Overweight from Equal-Weight at First Analysis... Applied Materials (AMAT) upgraded to Buy from Neutral at Nomura... Arctic Cat (ACAT) upgraded on valuation at BMO Capital... Beacon Roofing (BECN) upgraded to Overweight from Neutral at JPMorgan... Commvault (CVLT) upgraded to Overweight from Neutral at Piper Jaffray... Costco (COST) upgraded to Buy from Neutral at UBS... DISH (DISH) upgraded to Neutral from Sell at MoffettNathanson... Dime Community (DCOM) upgraded to Overweight from Neutral at Piper Jaffray... EQT Corporation (EQT) upgraded to Overweight from Equal Weight at Morgan Stanley... Enphase Energy (ENPH) upgraded to Neutral from Sell at Goldman... Goldman Sachs (GS) upgraded to Overweight from Equal Weight at Morgan Stanley... HeartWare (HTWR) upgraded to Buy from Neutral at BTIG... Highwoods Properties (HIW) upgraded to Buy from Hold at Jefferies... Hologic (HOLX) upgraded to Buy from Neutral at BTIG... HomeAway (AWAY) upgraded to Outperform from Market Perform at Cowen... Interxion (INXN) upgraded to Buy from Hold at Evercore ISI... MarketAxess (MKTX) upgraded to Outperform from Market Perform at Raymond James... Merit Medical (MMSI) upgraded to Outperform from Market Perform at Barrington... Murphy USA (MUSA) upgraded to Outperform from Market Perform at Wells Fargo... Pandora (P) upgraded to Outperform from Neutral at Macquarie... PayPal (PYPL) upgraded to Conviction Buy from Buy at Goldman... Pebblebrook Hotel (PEB) upgraded to Buy from Hold at Evercore ISI... Post Holdings (POST) upgraded to Buy from Hold at Stifel... Raymond James (RJF) upgraded to Buy from Neutral at Citi... Santander Mexico (BSMX) upgraded to Neutral from Sell at Citi... U.S. Bancorp (USB) upgraded to Overweight at Stephens... VF Corp. (VFC) upgraded to Overweight from Neutral at Piper Jaffray... Waddell & Reed (WDR) upgraded to Neutral from Sell at Citi... Whirlpool (WHR) upgraded to Strong Buy from Market Perform at Raymond James... Xilinx (XLNX) upgraded to Conviction Buy from Buy at Goldman... ZELTIQ (ZLTQ) upgraded to Conviction Buy from Buy at Goldman.
07/19/16
ADAM
07/19/16
INITIATION
Target $27
ADAM
Buy
Merit Medical initiated with a Buy at Canaccord
Canaccord initiated Merit Medical with a Buy rating, citing its expectations for accelerating revenue growth and eventual higher multiple expansion. Canaccord has a $27 price target on Merit Medical shares.
07/28/16
BRRR
07/28/16
DOWNGRADE
BRRR
Market Perform
Merit Medical downgraded to Market Perform from Outperform at Barrington
07/28/16
BRRR
07/28/16
DOWNGRADE
BRRR
Market Perform
Merit Medical downgraded to Market Perform at Barrington
As previously reported, Barrington analyst Michael Petusky downgraded Merit Medical to Market Perform from Outperform, citing his view that near-term price appreciation will be limited following the stock's 50% rally from its February lows.

TODAY'S FREE FLY STORIES

TYL

Tyler Technologies

$205.81

-0.06 (-0.03%)

08:40
02/20/18
02/20
08:40
02/20/18
08:40
Recommendations
Tyler Technologies analyst commentary  »

Tyler Technologies price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 21

    Feb

  • 22

    Feb

  • 26

    Feb

  • 26

    Feb

  • 26

    Feb

  • 28

    Feb

  • 14

    Mar

  • 15

    Mar

ECL

Ecolab

$131.49

-0.28 (-0.21%)

08:39
02/20/18
02/20
08:39
02/20/18
08:39
Earnings
Ecolab raises Q1 adjusted EPS view to 85c-93c from 84c-92c »

Consensus 85c. Ecolab…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 30

    May

NAVG

Navigators

$59.40

8.7 (17.16%)

08:39
02/20/18
02/20
08:39
02/20/18
08:39
Downgrade
Navigators rating change  »

Navigators downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XENE

Xenon Pharmaceuticals

$3.60

-0.025 (-0.69%)

08:37
02/20/18
02/20
08:37
02/20/18
08:37
Hot Stocks
Xenon Pharmaceuticals initiates Phase 1 clinical trial of XEN901 »

Xenon Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHMG

Chemung Financial

$43.90

0.09 (0.21%)

08:37
02/20/18
02/20
08:37
02/20/18
08:37
Upgrade
Chemung Financial rating change  »

Chemung upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$104.78

1.55 (1.50%)

08:36
02/20/18
02/20
08:36
02/20/18
08:36
Hot Stocks
Walmart sees ecommerce losses 'about the same' in FY19 vs. FY18 »

Walmart CFO Brett Biggs,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 28

    Feb

  • 07

    Mar

HII

Huntington Ingalls

$265.70

10.31 (4.04%)

08:36
02/20/18
02/20
08:36
02/20/18
08:36
Recommendations
Huntington Ingalls analyst commentary  »

Huntington Ingalls price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

ECL

Ecolab

$131.49

-0.28 (-0.21%)

08:35
02/20/18
02/20
08:35
02/20/18
08:35
Earnings
Ecolab sees FY18 adjusted EPS $5.25-$5.45, consensus $5.34 »

The 2018 outlook shown…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 30

    May

GPC

Genuine Parts

$99.83

-1.08 (-1.07%)

08:35
02/20/18
02/20
08:35
02/20/18
08:35
Hot Stocks
Genuine Parts reports Q4 sales for Automotive Group up 16.7% »

Fourth quarter sales for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 07

    Mar

IMAX

Imax

$22.60

-0.3 (-1.31%)

08:34
02/20/18
02/20
08:34
02/20/18
08:34
Hot Stocks
Imax announces record $35M global debut of Marvel Studios' Black Panther »

IMAX announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 05

    Mar

EXPD

Expeditors

$64.12

-0.07 (-0.11%)

08:33
02/20/18
02/20
08:33
02/20/18
08:33
Earnings
Expeditors reports Q4 EPS 92c, consensus 63c »

Reports Q4 revenue $1.9B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADI

Analog Devices

$86.09

0.69 (0.81%)

08:33
02/20/18
02/20
08:33
02/20/18
08:33
Upgrade
Analog Devices rating change  »

Analog Devices upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

GPC

Genuine Parts

$99.83

-1.08 (-1.07%)

08:32
02/20/18
02/20
08:32
02/20/18
08:32
Earnings
Genuine Parts sees FY18 EPS $5.60-$5.75, consensus $5.93 »

The company is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 07

    Mar

ECL

Ecolab

$131.49

-0.28 (-0.21%)

08:31
02/20/18
02/20
08:31
02/20/18
08:31
Earnings
Ecolab reports Q4 adjusted EPS $1.39, consensus $1.39 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 30

    May

SMP

Standard Motor

$48.20

0.3 (0.63%)

08:31
02/20/18
02/20
08:31
02/20/18
08:31
Earnings
Standard Motor reports Q4 cont ops EPS 54c, consensus 38c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

AAPL

Apple

$172.43

-0.56 (-0.32%)

08:31
02/20/18
02/20
08:31
02/20/18
08:31
Technical Analysis
Technical Take: Apple slips in early trading »

At time of writing the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

GPC

Genuine Parts

$99.83

-1.08 (-1.07%)

08:30
02/20/18
02/20
08:30
02/20/18
08:30
Earnings
Genuine Parts reports Q4 adjusted EPS $1.19, consensus $1.05 »

Reports Q4 revenue $4.2B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 07

    Mar

GPS

Gap

$33.27

-0.06 (-0.18%)

08:30
02/20/18
02/20
08:30
02/20/18
08:30
Hot Stocks
Gap announces departure of Gap brand President and CEO Jeff Kirwan »

Gap Inc. announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Mar

  • 18

    Mar

ANY

Sphere 3D

$2.33

0.0999 (4.48%)

, FALC

FalconStor

$0.19

0.003 (1.65%)

08:30
02/20/18
02/20
08:30
02/20/18
08:30
Options
Two option delistings on February 20th »

Option delistings…

ANY

Sphere 3D

$2.33

0.0999 (4.48%)

FALC

FalconStor

$0.19

0.003 (1.65%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RUSHA

Rush Enterprises

$42.77

-0.325 (-0.75%)

08:30
02/20/18
02/20
08:30
02/20/18
08:30
Recommendations
Rush Enterprises analyst commentary  »

Rush Enterprises price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:29
02/20/18
02/20
08:29
02/20/18
08:29
General news
Stocks point to lower start to week as Walmart weighs on Dow »

Stock futures are…

GOOD

Gladstone

$17.65

0.24 (1.38%)

08:28
02/20/18
02/20
08:28
02/20/18
08:28
Hot Stocks
Gladstone announces sale of Arlington, TX $5.6M »

Gladstone announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AAN

Aaron's

$43.40

-0.39 (-0.89%)

, LOW

Lowe's

$96.31

-0.2 (-0.21%)

08:28
02/20/18
02/20
08:28
02/20/18
08:28
Recommendations
Aaron's, Lowe's analyst commentary  »

Aaron's Progressive…

AAN

Aaron's

$43.40

-0.39 (-0.89%)

LOW

Lowe's

$96.31

-0.2 (-0.21%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Feb

  • 07

    Mar

LVMUY

LVMH

$61.94

0.68 (1.11%)

08:27
02/20/18
02/20
08:27
02/20/18
08:27
Hot Stocks
LVMH names Serge Brunschwig as Chairman and CEO of Fendi »

The LVMH Group announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WAB

Wabtec

$77.27

2.66 (3.57%)

08:26
02/20/18
02/20
08:26
02/20/18
08:26
Earnings
Wabtec reports Q4 adj. EPS 90c, consensus 92c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 26

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.